Cardinal Bernardin Cancer Center

Maywood, Illinois 60153

We've found

1 trials

at this facility

Efficacy, Safety and Tolerability of AG013 in Oral Mucositis Compared to Placebo When Administered Three Times Per Day

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Maywood, IL

Use our guide to learn which trials are right for you!